Showing results (391-400 of 400) with videos related to
Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 400 results.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.Diseases of the Colon and Rectum|November 1, 2005
Practice parameters for the surgical treatment of ulcerative colitisJeffrey L Cohen, Scott A Strong, Neil H Hyman, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.The Journal of Clinical Investigation|June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor functionPamela Wong, Jennifer A Foltz, Lily Chang, et al.Biotechnology for Biofuels|January 5, 2018
Development and use of a switchgrass (Panicum virgatum L.) transformation pipeline by the BioEnergy Science Center to evaluate plants for reduced cell wall recalcitranceRichard S Nelson, C Neal Stewart, Jiqing Gou, et al.Cancer Immunology Research|July 10, 2021
A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer ImmunotherapyMichelle K Becker-Hapak, Niraj Shrestha, Ethan McClain, et al.Plos One|November 28, 2012
Evaluating methods for isolating total RNA and predicting the success of sequencing phylogenetically diverse plant transcriptomesMarc T J Johnson, Eric J Carpenter, Zhijian Tian, et al.Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ MalignanciesLucila N Kerbauy, Nancy D Marin, Mecit Kaplan, et al.Nature Biotechnology|February 13, 2018
Sugar release and growth of biofuel crops are improved by downregulation of pectin biosynthesisAjaya K Biswal, Melani A Atmodjo, Mi Li, et al.Pageof 40